News & Articles

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

Dr. Vikramsingh Gujar, from Northwestern University, discusses his research on inflammatory disorders and why effective knowledge share is vital for scientific advancement

The assay is fueling discovery in preserved tissue samples to advance clinical translational research

The first-of-its-kind steerable delivery system is designed to seal the left atrial appendage in people who are at increased risk of stroke due to atrial fibrillation

OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients

Top talks presenting the latest technologies, research and applications are now available on demand

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies

Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D

Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally

A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

New findings pave way to potentially improved assessment of measurable residual disease in AML patients

New service reduces project time from months to weeks for biopharma customers

The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes

Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min